Literature DB >> 24950237

Prenatal therapy in developmental disorders: drug targeting via intra-amniotic injection to treat X-linked hypohidrotic ectodermal dysplasia.

Katharina Hermes1, Pascal Schneider2, Peter Krieg3, AnhThu Dang2, Kenneth Huttner4, Holm Schneider5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24950237     DOI： 10.1038/jid.2014.264

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  11 in total

1.  Assessing gestational age from histology of fetal skin: an autopsy study of 379 fetuses.

Authors:  J Ersch; T Stallmach
Journal:  Obstet Gynecol       Date:  1999-11       Impact factor: 7.661

2.  In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor.

Authors:  Simon N Waddington; Suzanne M K Buckley; Megha Nivsarkar; Sarah Jezzard; Holm Schneider; Thomas Dahse; Geoff Kemball-Cook; Maznu Miah; Nick Tucker; Margaret J Dallman; Mike Themis; Charles Coutelle
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

3.  A totally sex-linked gene in the house mouse.

Authors:  D S FALCONER
Journal:  Nature       Date:  1952-04-19       Impact factor: 49.962

4.  Prevalence and prevention of severe complications of hypohidrotic ectodermal dysplasia in infancy.

Authors:  Gert Blüschke; Kai-Dietrich Nüsken; Holm Schneider
Journal:  Early Hum Dev       Date:  2010-06-01       Impact factor: 2.079

5.  Systematic evaluation of exertional hyperthermia in children and adolescents with hypohidrotic ectodermal dysplasia: an observational study.

Authors:  Johanna E Hammersen; Valentin Neukam; Kai-Dietrich Nüsken; Holm Schneider
Journal:  Pediatr Res       Date:  2011-09       Impact factor: 3.756

6.  Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine.

Authors:  Uzma Shah; Bonny L Dickinson; Richard S Blumberg; Neil E Simister; Wayne I Lencer; W Allan Walker
Journal:  Pediatr Res       Date:  2003-02       Impact factor: 3.756

7.  Permanent correction of an inherited ectodermal dysplasia with recombinant EDA.

Authors:  Olivier Gaide; Pascal Schneider
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

8.  Early respiratory and ocular involvement in X-linked hypohidrotic ectodermal dysplasia.

Authors:  Jasna Dietz; Thomas Kaercher; Anne-Theres Schneider; Theodor Zimmermann; Kenneth Huttner; Ramsey Johnson; Holm Schneider
Journal:  Eur J Pediatr       Date:  2013-04-04       Impact factor: 3.183

Review 9.  Molecular aspects of hypohidrotic ectodermal dysplasia.

Authors:  Marja L Mikkola
Journal:  Am J Med Genet A       Date:  2009-09       Impact factor: 2.802

10.  Conserved features and evolutionary shifts of the EDA signaling pathway involved in vertebrate skin appendage development.

Authors:  Sophie Pantalacci; Arnaud Chaumot; Gérard Benoît; Alexa Sadier; Frédéric Delsuc; Emmanuel J P Douzery; Vincent Laudet
Journal:  Mol Biol Evol       Date:  2008-02-27       Impact factor: 16.240
View more
  11 in total

1.  Attenuation of Mammary Gland Dysplasia and Feeding Difficulties in Tabby Mice by Fetal Therapy.

Authors:  Mandy Wahlbuhl; Sonia Schuepbach-Mallepell; Christine Kowalczyk-Quintas; Angela Dick; Fabian B Fahlbusch; Pascal Schneider; Holm Schneider
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-06-01       Impact factor: 2.673

2.  Molecular Diagnostics and In Utero Therapeutics for Orofacial Clefts.

Authors:  J D Oliver; E C Turner; L R Halpern; S Jia; P Schneider; R N D'Souza
Journal:  J Dent Res       Date:  2020-07-01       Impact factor: 6.116

3.  Prenatal Treatment of X-Linked Hypohidrotic Ectodermal Dysplasia using Recombinant Ectodysplasin in a Canine Model.

Authors:  Carol A Margolis; Pascal Schneider; Kenneth Huttner; Neil Kirby; Timothy P Houser; Lee Wildman; Gary L Grove; Holm Schneider; Margret L Casal
Journal:  J Pharmacol Exp Ther       Date:  2019-04-18       Impact factor: 4.030

4.  Small-molecule Wnt agonists correct cleft palates in Pax9 mutant mice in utero.

Authors:  Shihai Jia; Jing Zhou; Christopher Fanelli; Yinshen Wee; John Bonds; Pascal Schneider; Gabriele Mues; Rena N D'Souza
Journal:  Development       Date:  2017-09-11       Impact factor: 6.868

5.  A case report of hypohidrotic ectodermal dysplasia: A mini-review with latest updates.

Authors:  Girish Gulab Meshram; Neeraj Kaur; Kanwaljeet Singh Hura
Journal:  J Family Med Prim Care       Date:  2018 Jan-Feb

6.  Safety and immunogenicity of Fc-EDA, a recombinant ectodysplasin A1 replacement protein, in human subjects.

Authors:  Iris Körber; Ophir D Klein; Patrick Morhart; Florian Faschingbauer; Dorothy K Grange; Angus Clarke; Christine Bodemer; Silvia Maitz; Kenneth Huttner; Neil Kirby; Caroline Durand; Holm Schneider
Journal:  Br J Clin Pharmacol       Date:  2020-04-24       Impact factor: 4.335

7.  Hypohidrotic ectodermal dysplasia: A case report with review and latest updates.

Authors:  Shubhangi P Bagdey; Rohit B Moharil; Alka Dive; Ashish Bodhade
Journal:  J Oral Maxillofac Pathol       Date:  2022-02-28

8.  Functional and clinical analysis of five EDA variants associated with ectodermal dysplasia but with a hard-to-predict significance.

Authors:  Sare Gökdere; Holm Schneider; Ute Hehr; Laure Willen; Pascal Schneider; Sigrun Maier-Wohlfart
Journal:  Front Genet       Date:  2022-07-18       Impact factor: 4.772

9.  Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse.

Authors:  Frederic F Depreux; Lingyan Wang; Han Jiang; Francine M Jodelka; Robert F Rosencrans; Frank Rigo; Jennifer J Lentz; John V Brigande; Michelle L Hastings
Journal:  Nucleic Acids Res       Date:  2016-09-28       Impact factor: 16.971

10.  Transamniotic mesenchymal stem cell therapy for neural tube defects preserves neural function through lesion-specific engraftment and regeneration.

Authors:  Xiaowei Wei; Wei Ma; Hui Gu; Dan Liu; Wenting Luo; Yuzuo Bai; Weilin Wang; Vincent Chi Hang Lui; Peixin Yang; Zhengwei Yuan
Journal:  Cell Death Dis       Date:  2020-07-13       Impact factor: 8.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.